Research member at the Institute, Marie-Claude Bourgeois-Daigneault, and her team at the CRCHUM have published a study in Nature Communications showing how they have succeeded in creating a personalized, effective and anti-cancer-specific vaccine.
The vaccine combines oncolytic viruses with small synthetic molecules (peptides) specific to the targeted cancer. It allows it to attack the cancer both by killing it directly and by inducing an immune response through the virus. The effectiveness of the immunization has been demonstrated in an animal model.
John Stagg : New scientific article
9 September 2022
Research member at the Institute, John Stagg, and other researchers have published a major scientific paper in the prestigious journal […]
Ride for Dad
24 August 2022
Ride for Dad is a motorcycle ride organized by the organization of the same name. On September 10th, a ride […]